First, do no harm.


H ET AL1 are to be commended for their continued study of fluconazole resistance, one of the potential negative effects of systemic antifungal prophylaxis. In this issue of Pediatrics, the authors provide modest new evidence to support fluconazole use, provided that we first correctly investigate the risks and benefits of fluconazole prophylaxis. All drugs… (More)
DOI: 10.1542/peds.2008-0068

Cite this paper

@article{Benjamin2008FirstDN, title={First, do no harm.}, author={Daniel Kelly Benjamin}, journal={Pediatrics}, year={2008}, volume={121 4}, pages={831-2} }